Champions Oncology (CSBR) Reports Q3 Loss of $0.11
Tweet
Share
E-mailGet Alerts CSBR Hot Sheet
Price: $5.11 +0.79%
Financial Fact:
Research and development: 1.21M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Research and development: 1.21M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Champions Oncology (NASDAQ: CSBR) reported Q3 EPS of ($0.11). Revenue for the quarter came in at $3.6 million, versus $0 reported last year.
For earnings history and earnings-related data on Champions Oncology (CSBR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'
- Is Treasury selloff a major issue for stock market bulls?
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
